Published in Sarcoidosis Vasc Diffuse Lung Dis on October 01, 2002
A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med (2010) 1.98
Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Rep (2014) 0.96
Granuloma formation in pulmonary sarcoidosis. Front Immunol (2013) 0.93
Pulmonary Sarcoidosis Induced by Adalimumab: A Case Report and Literature Review. Yonsei Med J (2016) 0.88
Dramatic response to infliximab in refractory neurosarcoidosis. Ann Indian Acad Neurol (2010) 0.83
Infliximab therapy for hepatic and intestinal sarcoidosis. Gastroenterol Hepatol (N Y) (2007) 0.82
Alveolar macrophage cathelicidin deficiency in severe sarcoidosis. J Innate Immun (2012) 0.78
Esophageal sarcoidosis: a review of cases and an update. ISRN Gastroenterol (2013) 0.78
Chitotriosidase in the Pathogenesis of Inflammation, Interstitial Lung Diseases and COPD. Allergy Asthma Immunol Res (2014) 0.77
5q Minus Myelodysplasia Associated with Multiple Epithelioid Granulomas within Conventional Renal Cell Carcinoma. Case Rep Pathol (2012) 0.75
Cigarette smoking and male sex are independent and age concomitant risk factors for the development of ocular sarcoidosis in a New Orleans sarcoidosis population. Sarcoidosis Vasc Diffuse Lung Dis (2015) 0.75
In vivo evaluation of TNF-alpha in the lungs of patients affected by sarcoidosis. Biomed Res Int (2015) 0.75
Can persistent tumor necrosis factor release lead to refractory sarcoidosis? Sarcoidosis Vasc Diffuse Lung Dis (2002) 0.75
Cytokine modulators in the treatment of sarcoidosis. Rheumatol Int (2011) 0.75
Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 6.71
Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet (2005) 4.23
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med (2006) 4.20
Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc Natl Acad Sci U S A (2012) 2.42
A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med (2006) 2.28
Toward the blood-borne miRNome of human diseases. Nat Methods (2011) 2.14
Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin Immunol (2010) 1.80
Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 1.80
A novel sarcoidosis risk locus for Europeans on chromosome 11q13.1. Am J Respir Crit Care Med (2012) 1.56
Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet (2008) 1.54
Genome-wide association analysis reveals 12q13.3-q14.1 as new risk locus for sarcoidosis. Eur Respir J (2012) 1.47
The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J Immunol (2004) 1.44
CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthritis Rheum (2007) 1.38
Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J Allergy Clin Immunol (2005) 1.37
Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry. Nat Genet (2011) 1.30
Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 1.30
P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema. Am J Respir Cell Mol Biol (2010) 1.27
The P2Y14 receptor of airway epithelial cells: coupling to intracellular Ca2+ and IL-8 secretion. Am J Respir Cell Mol Biol (2005) 1.21
Serotoninergic receptors on human airway epithelial cells. Am J Respir Cell Mol Biol (2006) 1.18
Sarcoidosis--immunopathogenetic concepts. Semin Respir Crit Care Med (2007) 1.15
Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation. PLoS One (2013) 1.14
IL-10-producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients. J Allergy Clin Immunol (2006) 1.11
Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema. J Immunol (2010) 1.11
Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis. Am J Respir Crit Care Med (2010) 1.11
Immunologic response of sarcoidosis. Semin Respir Crit Care Med (2010) 1.10
Pulmonary chemokines and their receptors differentiate children with asthma and chronic cough. J Allergy Clin Immunol (2005) 1.07
Non-invasive biomarkers in pulmonary fibrosis. Respirology (2009) 1.06
Purinergic receptor type 6 contributes to airway inflammation and remodeling in experimental allergic airway inflammation. Am J Respir Crit Care Med (2011) 1.05
CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II. Respir Res (2005) 1.03
Essential role of osteopontin in smoking-related interstitial lung diseases. Am J Pathol (2009) 0.98
Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2. Gastroenterology (2008) 0.97
Prostaglandin E2 reinforces the activation of Ras signal pathway in lung adenocarcinoma cells via EP3. FEBS Lett (2002) 0.97
A role for MCP-1/CCR2 in interstitial lung disease in children. Respir Res (2005) 0.95
Activation of human alveolar macrophages via P2 receptors: coupling to intracellular Ca2+ increases and cytokine secretion. J Immunol (2008) 0.94
Impact of impaired inspiratory muscle strength on dyspnea and walking capacity in sarcoidosis. Chest (2006) 0.94
Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med (2007) 0.92
Interleukin-18 expression by alveolar epithelial cells type II in tuberculosis and sarcoidosis. FEMS Immunol Med Microbiol (2006) 0.91
Serum level of CC-chemokine ligand 18 is increased in patients with non-small-cell lung cancer and correlates with survival time in adenocarcinomas. PLoS One (2012) 0.89
Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Am J Respir Crit Care Med (2006) 0.89
CCL18 production is decreased in alveolar macrophages from cigarette smokers. Inflammation (2009) 0.89
Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis. Clin Immunol (2003) 0.87
CC-chemokine ligand 18 induces epithelial to mesenchymal transition in lung cancer A549 cells and elevates the invasive potential. PLoS One (2013) 0.86
Respiratory muscle function in interstitial lung disease. Eur Respir J (2012) 0.85
The impact of gas exchange measurement during exercise in pulmonary sarcoidosis. Respir Med (2010) 0.85
Systemic immune cell activation in a subgroup of patients with idiopathic pulmonary fibrosis. Respiration (2003) 0.84
Study of C-C chemokine receptor 2 alleles in sarcoidosis, with emphasis on family-based analysis. Am J Respir Crit Care Med (2005) 0.84
Genetics of sarcoidosis. Clin Chest Med (2008) 0.84
Pathogenesis of sarcoidosis. Presse Med (2012) 0.82
Female-specific association of C-C chemokine receptor 5 gene polymorphisms with Löfgren's syndrome. J Mol Med (Berl) (2008) 0.82
The EvA study: aims and strategy. Eur Respir J (2012) 0.81
Genotyping in the MHC locus: potential for defining predictive markers in sarcoidosis. Respir Res (2001) 0.81
Differential gene expression pattern in alveolar macrophages of patients with sarcoidosis and tuberculosis. J Mol Med (Berl) (2004) 0.80
Functional characterization of histamine receptor subtypes in a human bronchial epithelial cell line. Int J Mol Med (2006) 0.80
Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease. Cytokine (2013) 0.79
Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis. Eur Respir J (2014) 0.79
CCL18 -- potential biomarker of fibroinflammatory activity in chronic periaortitis. J Rheumatol (2012) 0.79
Sarcoidosis from bench to bedside: a state-of-the-art series for the clinician. Eur Respir J (2012) 0.78
Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease. J Mol Med (Berl) (2005) 0.78
Tumor-cell co-culture induced alternative activation of macrophages is modulated by interferons in vitro. J Interferon Cytokine Res (2012) 0.78
Repeated segmental allergen provocation: reassessment of provocation dose. J Allergy Clin Immunol (2008) 0.78
Inflammatory markers in exhaled breath condensate following lung resection for bronchial carcinoma. Respirology (2008) 0.78
Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis. Arthritis Care Res (Hoboken) (2013) 0.77
Roflumilast-N-oxide induces surfactant protein expression in human alveolar epithelial cells type II. PLoS One (2012) 0.77
Analysis of differentially regulated mRNAs in monocytic cells induced by in vitro stimulation with Kveim-Siltzbach test reagent. Exp Lung Res (2004) 0.76
Update in diffuse parenchymal lung disease 2011. Am J Respir Crit Care Med (2012) 0.76
A genome-wide linkage analysis in 181 German sarcoidosis families using clustered biallelic markers. Chest (2010) 0.76
mRNA and miRNA analyses in cytologically positive endobronchial ultrasound-guided transbronchial needle aspiration: implications for molecular staging in lung cancer patients. Cancer Cytopathol (2014) 0.76
Acute lung affection in an endurance-trained man under amiodarone medication. Ger Med Sci (2005) 0.75
Evidence-based recommendations in idiopathic pulmonary fibrosis: a year is a long time in interstitial lung disease. Am J Respir Crit Care Med (2012) 0.75
Usefulness of Cyclophosphamide Pulse Therapy in Interstitial Lung Diseases. Respiration (2016) 0.75
Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis. Respiration (2016) 0.75